Sarcopenic obesity: molecular clues to a better understanding of its pathogenesis?
The DOI matches its Crossref record; 124 of the 125 references it cites were found in a registry or an index.
Abstract
An age-dependent decline in skeletal muscle mass, strength, and endurance during the aging process is a physiological development, but several factors may exacerbate this process, leading to the threatening state of sarcopenia, frailty, and eventually higher mortality rates. Obesity appears to be such a promoting factor and has been linked in several studies to sarcopenia. The reason for this causal association remains poorly understood. Notwithstanding the fact that a higher body mass might simply lead to diminished physical activity and therefore contribute to a decline in skeletal muscle, several molecular mechanisms have been hypothesized. There could be an obesity derived intracellular lipotoxicity (i.e., elevated intramuscular levels of lipids and their derivatives), which induces apoptosis by means of an elevated oxidative stress. Paracrine mechanisms and inflammatory cytokines, such as CRP and IL-6 could be confounders of the actual underlying pathological mechanism. Due to a cross-talk of the hypothalamo-pituitary axis with nutritional status, obese subjects are more in a catabolic state of metabolism, with a higher susceptibility to muscle wasting under energy restriction. Obesity induces insulin resistance in the skeletal muscle, which consequently leads to perturbed metabolism, and misrouted signaling in the muscle cells. In obesity, muscle progenitor cells could differentiate to an adipocyte-like phenotype as a result of paracrine signals from (adipo)cytokines leading to a reduced muscular renewal capacity. The present review outlines current knowledge concerning possible pathways, which might be involved in the molecular pathogenesis of sarcopenic obesity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The regeneration potential of muscle is impaired, which might promote fibrosis, thereby promoting insulin resistance76–79, partially owing to impaired mitochondrial fatty acid oxidation and increased lipolysis76,80.”
From Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies (2018) · cites this paper as [77]
In the citing paper
“These cytokines induce muscle atrophy by increasing apoptosis and upregulating proteosomal decay of filament proteins [42].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [42]
In the citing paper
“Thus, SO decreases the physical functional capacity to a higher degree than sarcopenia or obesity separately [13, 14].”
From The critical role of oxidative stress in sarcopenic obesity (2021) · cites this paper as [14]
In the citing paper
“Also, adiponectin and growth hormone (GH) decrease their secretion in obesity and aging, inducing adverse effects on muscle protein synthesis.”
From The critical role of oxidative stress in sarcopenic obesity (2021) · cites this paper as [14]
In the citing paper
“TNF-α is a proinflammatory cytokine that increases in aging and obesity, promotes protein degradation, decreases protein synthesis, and inhibits myogenic differentiation [14, 45].”
From The critical role of oxidative stress in sarcopenic obesity (2021) · cites this paper as [14]
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Wenz, T., Rossi, S. G., Rotundo, R. L., Spiegelman, B. M., & Moraes, C. T. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911570106 · Cited by 600 · cited 3×
“Transgene animals showed a lower fat percentage, together with a higher mitochondrial capacity and a higher capacity for oxidative phosphorylation and increased insulin sensitivity, suggesting a PGC-1a-mediated mitochondrial dysfunction in muscular aging (Wenz et al. 2009).”
BackgroundInfluentialRetractedSarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601 · cited 4×
“8 or\1 m/s) for diagnosing of sarcopenia (Cruz-Jentoft et al. 2010; Fielding et al. 2011).”
BackgroundInfluentialAging: a theory based on free radical and radiation chemistry
Harman, D. (1956) · Journal of Gerontology · doi:10.1093/geronj/11.3.298 · Cited by 8,567 · cited 2×
“increased reactive oxygen species formation (ROS), an age-dependent decrease in central mitochondrial regulator peroxisome-proliferator-activated-receptor-c coactivator 1 a (PGC-1a) and induced mitochondrial apoptosis of muscle cells are important (Harman 1956; Anderson and Prolla 2009; Marzetti et al. 2010).”
BackgroundAmerican College of Sports Medicine position stand
Otis, C. L. (1997) · Medical Entomology and Zoology · Cited by 4,407
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238 · cited 3×
“Adiponectin increases insulin sensitivity by facilitating glucose uptake in skeletal muscle and adipose tissue and stimulates fatty acid oxidation (Yamauchi et al. 2002).”
BackgroundFielding, R. A., Vellas, B., Evans, W. J., Bhasin, S., Morley, J. E., Newman, A. B., Abellan van Kan, G., Andrieu, S., Bauer, J., Breuille, D., et al. (2011) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.01.003 · Cited by 3,256 · cited 3×
“8 or\1 m/s) for diagnosing of sarcopenia (Cruz-Jentoft et al. 2010; Fielding et al. 2011).”
BackgroundInfluentialSelf-citationAdipocytokines: mediators linking adipose tissue, inflammation and immunity
Tilg, H., & Moschen, A. R. (2006) · Nature Reviews Immunology · doi:10.1038/nri1937 · Cited by 3,188 · cited 6×
“It decreases the inflammatory response by inhibiting TNFa and interleukin-c (ILc) secretion and elevates production of anti-inflammatory cytokines, such as IL-10 and IL-1 receptor antagonist, by human monocytes, macrophages, and dendritic cells (Tilg and Moschen 2006).”
BackgroundInfluentialCloning of adiponectin receptors that mediate antidiabetic metabolic effects
Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., Sugiyama, T., Miyagishi, M., Hara, K., Tsunoda, M., et al. (2003) · Nature · doi:10.1038/nature01705 · Cited by 3,176
DONNELLY, J. E., BLAIR, S. N., JAKICIC, J. M., MANORE, M. M., RANKIN, J. W., & SMITH, B. K. (2009) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181949333 · Cited by 2,658 · cited 1×
“Actually in older people with obesity, it leads to muscle mass gain and improves body composition (Donnelly et al. 2009).”
BackgroundMuscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
Pedersen, B. K., & Febbraio, M. A. (2008) · Physiological Reviews · doi:10.1152/physrev.90100.2007 · Cited by 2,388 · cited 1×
“After release in the blood stream, IL-6 enhances gluconeogenesis in the liver and lipolysis in adipose tissue (Pedersen and Febbraio 2008).”
Background
Cited by
Items 101–150 of 150
Role of immunity and inflammation in sarcopenic obesity
Ma, Y. F., Li, X., Lin, X., Zhang, K., & Leng, J. (2025) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2025.110077 · Cited by 8
Miedany, Y. M. E., Gadallah, N. A., & Toth, M. (2022) · Egyptian Rheumatology and Rehabilitation · doi:10.1186/s43166-022-00161-x · Cited by 6
“The age-related chronic inflammation, often referred to as “inflammaging,” leads to a decrease in both muscle mass and strength in addition to bone loss [25].”
BackgroundSarcopenic Obesity: The Underlying Molecular Pathophysiology and Prospect Therapies
Meiliana, A., Dewi, N. M., Defi, I. R., Rosdianto, A. M., Qiantori, A. A., & Wijaya, A. (2024) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v16i4.3176 · Cited by 7
“(44 ) Reduced physical activity, a low metabolic rate, and a myokine shortage brought on by sarcopenia all contribute to a proinflammatory response that worsens obesity.”
BackgroundLi, S., Huang, H., Shi, H., Chen, Z., Jiang, S., Yu, X., Ren, K., Huang, Q., & Zhao, Q. (2025) · Innovation in Aging · doi:10.1093/geroni/igaf065 · Cited by 5
Ayçiçek, G. Ş., Baş, A. O., Karabulut, E., & Halil, M. G. (2025) · Acta Clinica Belgica · doi:10.1080/17843286.2025.2583187 · Cited by 5
Molecular mechanisms of exercise providing therapeutic rationale to counter sarcopenia
Kwon, K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822146-4.00002-8 · Cited by 4
Insight on sarcopenic obesity and epicatechin as a promising treatment option
Sabarathinam, S., Dhanasekaran, D., & Ganamurali, N. (2023) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2023.102856 · Cited by 7
Reynolds, T., Mills, N. R., Hoyte, D., Ehnstrom, K., & Arata, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910278 · Cited by 6
Glukosestoffwechsel im fortgeschrittenen Lebensalter
Laurentius, T., Freitag, M., Eitner, J., Eisert, A., Bertsch, T., & Bollheimer, L. C. (2019) · Der Internist · doi:10.1007/s00108-018-0542-y · Cited by 6
Self-citationLee, S. R., Lee, S. Y., Cho, Y. H., Lee, Y., Choi, J. I., Kwon, R. J., Son, S. M., Lee, J. G., Yi, Y. H., Tak, Y. J., et al. (2025) · Nutrients · doi:10.3390/nu17060992 · Cited by 4
“Sarcopenic obesity is caused by various unhealthy lifestyles and physical factors related to aging [14–16].”
de Luis, D. A., Primo, D., Izaola, O., Lite, I. S., & Gómez, J. J. L. (2025) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2025.09.032 · Cited by 3
Impact of Type 2 Diabetes on Skeletal Muscle Mass and Quality
Sala, D., & Zorzano, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801585-8.00007-5 · Cited by 3
Sarcopenia as a severe organ failure, its diagnosing and present therapeutic possibilities
Topinková, E. (2018) · Vnitřní lékařství · doi:10.36290/vnl.2018.149 · Cited by 5
Omaña‐Guzmán, I., Kammar‐García, A., Gutiérrez‐Robledo, L. M., & Rosas‐Carrasco, Ó. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1499453 · Cited by 3
“This contributes to increased inflammatory cytokines, lipotoxicity, and insulin resistance, which are associated with mitochondrial dysfunction, impaired muscle protein synthesis, and muscle atrophy (38, 40).”
Huang, J.-M., & Yang, J. (2025) · Surgery Today · doi:10.1007/s00595-025-03058-2 · Cited by 2
“…cytokines generated by the tumor microenvironment (e.g. interleukin-6 and tumor necrosis factor-α) facilitate the redistribution of fat tissue and infiltration of intramuscular fat by stimulating the differentiation of muscle precursor cells into an adipocyte-like phenotype [25, 26].”
Carollo, L., Lawson, E. A., Stanley, T. L., Wang, J., Bhattacharya, R., Bishop, D. J., Carmichael, O. T., Esser, K. A., Febbraio, M. A., Fielding, R. A., et al. (2026) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2026.101262 · Cited by 3
Meisel, P., Pagels, S., Grube, M., Jedlitschky, G., Völzke, H., & Kocher, T. (2020) · Clinical Oral Investigations · doi:10.1007/s00784-020-03594-w · Cited by 2
“Hand grip strength was used as a proxy for the general health state of the participants strongly associated with obesity [19].”
MethodSarcopenia and non-alcoholic fatty liver disease - complex pathogenetic relationships
Ахмедов, В. А., & Marinenko, V. S. (2025) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-229-9-110-118 · Cited by 2
Liu, J., Yao, X., Shi, M., Xu, Z.-Y., Wu, Y., Shi, X., Li, M., & Du, X.-R. (2025) · Journal of bone oncology · doi:10.1016/j.jbo.2025.100670 · Cited by 2
“In obese patients, cytokine paracrine signaling can cause muscle progenitor cells to differentiate into an adipocyte-like phenotype, leading to muscle loss and increased fat infiltration [42].”
Underlying mechanisms of sarcopenic obesity
Rauen, M., Bollheimer, L. C., & Nourbakhsh, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822146-4.00005-3 · Cited by 3
Self-citationNascimento, G. M., Longo, G. Z., Valmorbida, A., Ferreira, F. G., & Trindade, E. B. S. D. M. (2024) · Cadernos de Saúde Pública · doi:10.1590/0102-311xen109823 · Cited by 3
“This expectation is based on previous findings that adults aged from 20 to 59 years have a prevalence of estimated SO ranging 5-10% 27 .”
BackgroundMethodCarmeli, E. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.93418 · Cited by 5
Abbasy, A. N., Abdel-Naby, H., & Ellakany, W. I. (2023) · Egyptian Liver Journal · doi:10.1186/s43066-023-00265-9 · Cited by 1
“Metabolic syndrome, in addition to a fat-rich, protein-poor diet as well as physical inactivity, leads to insulin resistance in addition to increased release of inflammatory adipokines, leading to muscle catabolism as well as obesity [24].”
BackgroundSong, G. Y. (2025) · Korean Journal of Geriatrics & Gerontology · doi:10.15656/kjgg.2025.26.1.9 · Cited by 1
The role of dietary fat intake in muscle decline: a new perspective based on comprehensive evidence
Wu, T., Xia, J., Feng, Z., Wang, Y., Wang, J. P., Liao, W., & Sun, G. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.108400 · Cited by 1
Developing Strategies in Skeletal Muscle Mass Measurements for Diagnosing Sarcopenia Disease
Shanthi, K. G., Devi, S., Sesha Vidhya, S., Rajagopal, R., Sarala, B., & Harinee, G. A. (2024) · International Conference on Sustainable Computing and Smart Systems (ICSCSS) · doi:10.1109/icscss60660.2024.10625582 · Cited by 1
Troshina, E. A., Bogdanova, V. O., & Umarkhadzhieva, Z.-S. R. (2025) · Obesity and metabolism · doi:10.14341/omet13180 · Cited by 1
Background and Management of Muscular Atrophy
Cseri, J. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.90959 · Cited by 2
Ayoola, M. D. (2022) · American Journal of Biomedical Science & Research · doi:10.34297/ajbsr.2022.17.002376 · Cited by 3
Gross, D. C., Cheever, C. R., & Batsis, J. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-40116-9_38 · Cited by 1
Sostmann, N. (2018) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-6727
Okun, J. G., Rusu, P. M., Chan, A. Y., Yap, Y. W., Sharkie, T., Schumacher, J., Schmidt, K. V., Zota, A., Hille, S. S., Jungmann, A., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.25.115709
Magnetic Resonance Imaging for Drug Development
Kim, J. K. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-33-6064-8_9
Batsis, J. A. (2015) · Springer eBooks · doi:10.1007/978-3-319-12125-3_38-1
Batsis, J. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-11251-0_38
Gross, D. C., Cheever, C. R., & Batsis, J. A. (2023) · Springer eBooks · doi:10.1007/978-3-319-12125-3_38-2
Abnormal fatty acid and amino acid metabolism in patients with sarcopeniaPreprint
Ma, X., Bian, A.-L., & Hu, S. (2024) · Research Square · doi:10.21203/rs.3.rs-3863000/v1
Factors associated with muscle massPreprint
Zhu, X., Zheng, Y., Gao, L., Liu, Y., Wang, Y., Zhang, W., Hu, T. T., & Yang, M. (2024) · Research Square · doi:10.21203/rs.3.rs-4340017/v1
Lan, J., Guo, H., Zou, J., Xue, J., Ni, H., Wang, L., Ren, T., Chai, S., Jiang, H., Gou, C., et al. (2024) · Portal hypertension & cirrhosis · doi:10.1002/poh2.89
Sarkopene Adipositas im Alter: Ursachen, Folgen und Behandlungsansätze
Rippl, M., Drey, M., & Schluessel, S. (2025) · Adipositas - Ursachen Folgeerkrankungen Therapie · doi:10.1055/a-2492-9415
“…nur im Fettgewebe selbst, sondern auch in der Mus-kulatur (sogenannte Myosteatose) sowie in nahezu allen weiteren Organen ablagern, entsteht eine ubiquitäre, zwar niederschwelli - ge, jedoch dauerhafte Entzündung im gesamten Körper, die die Entwicklung einer sarkopenen Adipositas begünstigt [12].”
Liu, Q., Pan, S., Tang, M., & Yin, S. (2025) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188251332055
“10 Previous studies have established a connection between obesity, sarcopenia, and osteoporosis, a triad known as “osteosarcopenic obesity” (OSO), which can lead to impaired function and systemic metabolic dysregulation.”
The Road to Sarcopenia Management: Causes and Therapeutic Options
Gwon, D. Y., Kim, H. S., & Lee, J. W. (2025) · The Journal of the Korean Orthopaedic Association · doi:10.4055/jkoa.2025.60.4.286
Research Progress on the Correlation between Body Composition and Frailty in the Elderly
程, 圣. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.161138
Ilchenko, L. Y., Ахмедов, В. А., Vinnitskaya, E. V., Иванович, Д. Е., Myazin, R. G., Nikitin, I. G., Tikhomirova, A. S., Khoroshilov, I., Myazin, R. G., Александровна, Э. О., et al. (2026) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-236-4-3-36
Shin, S., Jeong, J., Kim, M.-J., Jang, M. J., Park, C. L., Kim, S., & Kwon, E. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1861420
El-Oueslati, H., Youssef, L., Manuel, R. F. J., Boucher, L., Tannou, T., Brodeur, C., Andriamampionona, F., Kergoat, M., & Aubertin‐Leheudre, M. (2026) · medRxiv · doi:10.64898/2026.09.06.26359363
Metadata
- Authors
- Kob, R., Bollheimer, L. C., Bertsch, T., Fellner, C., Djukic, M., Sieber, C. C., & Fischer, B. E.
- Affiliations
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Paracelsus Medizinische Privatuniversität (DE)
- University Hospital Regensburg (DE)
- Universitätsmedizin Göttingen (DE)
- Corresponding author
- Fischer, Barbara E.
- ORCID
- Venue
- Biogerontology
- Published
- 2014-11-07
- Volume
- 16
- Issue
- 1
- Pages
- 15-29
- ISSN
- 1389-5729 (ISSN-L)
- 1573-6768
- OpenAlex
- W2087089023
- Cited by
- 151
- References
- 125
- Citations by year
- 2026: 7 · 2025: 18 · 2024: 14 · 2023: 15 · 2022: 14 · 2021: 9 · 2020: 18 · 2019: 10 · 2018: 11 · 2017: 13 · 2016: 12 · 2015: 10
- FWCI
- 1.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Biogerontology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bayerische Forschungsstiftung
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- sarcopenic obesity, sarcopenia, obesity, pathogenesis, lipotoxicity, oxidative stress, apoptosis, inflammatory cytokines, C-reactive protein, interleukin-6, hypothalamic-pituitary axis, caloric restriction, insulin resistance, skeletal muscle, muscle progenitor cells, adipogenesis, muscle atrophy, aging
- MeSH terms
- Aging, Humans, Insulin Resistance, Obesity, Signal Transduction, Muscle, Skeletal, Muscle Weakness, Sarcopenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.